Case 2:13-cv-00391-ES-JAD Document 54 Filed 04/15/14 Page 1 of 2 PageID: 641
`Case 2:13-cv-00391-ES-JAD Document 54 Filed 04/15/14 Page 1 of 2 PageID: 641
`Charles M. Lizza
`
`
`
`Phone:
`
`(973)286-6715
`
`Fax:
`
`(973)286—6815
`
`clizza@saul.com
`www.saul.com
`
`April 15, 2014
`
`VIA ECF & FEDEX
`
`The Honorable Joseph A. Dickson, U.S.M.J.
`United States District Court
`
`Martin Luther King, Jr. Federal Building
`50 Walnut Street, Room 2060
`Newark, New Jersey 07102
`
`Re:
`
`Jazz Pharmaceuticals, Inc. v. Amneal Pharmaceuticals, LLC
`Civil Action No. 13—391 (ESMAD)
`
`Dear Judge Dickson:
`
`This firm, together with Quinn Emanuel Urquhart & Sullivan, LLP and Richard G. Greco
`PC, represents plaintiff Jazz Pharmaceuticals, Inc. (“Jazz”) in the above-captioned action. We
`write regarding defendant Amneal Pharmaceuticals, LLC’s (“Amneal”) April 14, 2014 letter to"
`the Court concerning Amneal’s request for “guidance” on its request for consolidation of this
`matter with the matter Jazz Pharmaceuticals, Inc. v. Par Pharmaceutical, Inc. , Civil Action No.
`
`13-7884 (ES)(MAH). D1. 53.
`
`-
`
`Amneal’s request is premature. Amneal states that the “parties have discussed this issue
`on numerous occasions.” This is incorrect. Jazz learned of Amneal’s scheduling proposal this
`morning and the parties hope to have their first meet and confer later this week.1 Once Jazz has
`reviewed Amneal’s proposal and the parties have met-and-conferred, the parties will likely be
`seeking the Court’s assistance either to (l) consolidate if the parties reach agreement or (2)
`adjudicate a motion if the parties do not agree. In any event, Amneal’s attempt to argue the issue
`now is premature.
`
`Additionally, Amneal states in its letter that it has “invited” non-party Par to the status
`conference. Regardless of the status of the parties’ discussions concerning consolidation, the
`April 16 status call is between Amneal, Jazz, and the Court. The cases are not consolidated, and
`Amneal cannot de facto consolidate these matters by “inviting” Par to the status conference.
`
`1 Any proposal regarding consolidation would have to address Local Patent Rule issues that may weigh
`against consolidation. For example, the Amneal matter has advanced much further under the Local Patent
`Rules than the Par case. Opening Markman briefs are due in the Amneal case in two weeks -- the same
`day as the Par case’s Rule 16 conference. As Amneal’s letter notes, the Par case has four additional
`patents that will not be addressed in the context of those proceedings.
`
`One Riverfront Plaza, Suite 1520 0 Newark, NJ 07l02-5426 9 Phone: (973) 286-6700 0 Fax: (973) 236—6800
`
`
`DELAWARE
`
`NEW YORK
`NEW JERSEY
`MARYLAND MASSACHUSETTS
`A DELAWARE LIMITED LIABILITY PARTNERSHIP
`
`PENNSYLVANIA WASHINGTON, DC
`
`
`
`1
`
`

`

`Case 2:13-cv-00391-ES-JAD Document 54 Filed 04/15/14 Page 2 of 2 PageID: 642
`Case 2:13-cv-00391-ES-JAD Document 54 Filed 04/15/14 Page 2 of 2 PageID: 642
`
`Hon. Joseph A. Dickson, U.S.M.J.
`April 15, 2014
`Page 2
`
`Further, there is no Discovery Confidentiality Order entered in the Par case, which would
`hamper the parties’ ability to discuss the case. Jazz therefore objects to Amneal’s presumptive
`attempt to invite Par’s counsel to the April 16 conference call with the Court.
`
`Re
`
`tfully yours,
`
`C
`
`es M. Lizza
`
`cc:
`
`All Counsel (via e-mail)
`
`
`
`